Position in DNTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,042,631
+$1,548,181 QoQ
Shares Held
107,753
-40.7% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Atom Investors LP holds $125,831,094 across 42 Biotechnology names. DNTH ranks #2 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
319,316 | $16,687,454 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
This page
|
107,753 | $9,042,631 | |
| 3 | CELC |
Celcuity Inc.
|
76,321 | $8,711,278 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
190,773 | $7,272,266 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
21,196 | $6,829,139 | |
| 6 | IMNM |
Immunome Inc.
|
306,880 | $6,711,465 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
158,509 | $6,295,977 | |
| 8 | ERAS |
Erasca, Inc.
|
345,587 | $5,591,597 |
All Filings in DNTH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,042,631 | 107,753 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,494,450 | 181,860 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,401,845 | 61,038 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||